The 11th International AIDS Society Conference on HIV Science

Download All
July 18-21, 2021; Virtual
CCO is the official provider of online scientific analysis for IAS 2021 through rapid post-conference webinars by expert faculty, Capsule Summaries, downloadable slides, podcasts, and ClinicalThought commentaries.
Adeeba Kamarulzaman, MBBS, FRACP, FASc

Highlights

Slidesets TANGO: Post-Hoc Analysis of Viral Replication for 2-Drug DTG/3TC Regimen vs 3- or 4-Drug TAF-Based Regimen Through Week 96
Slidesets FLAIR: Week 124 Results of Long-Acting Injectable Cabotegravir + Rilpivirine
Slidesets Phase IIb Protocol 011 Safety Analysis at Week 96: Islatravir Plus Doravirine Following Islatravir, Doravirine, Lamivudine Induction
Slidesets Outcomes of Dolutegravir Use in Children and Adolescents Living With HIV-1 in Sub-Saharan Africa
Slidesets CUSTOMIZE: Implementation-Effectiveness Study of Long-Acting Cabotegravir and Rilpivirine Injection in US Healthcare Settings
Slidesets ZeNix: Pretomanid, Bedaquiline, and Varied Doses and Durations of Linezolid in Highly Resistant TB
Slidesets CALIBRATE: Interim Week 28 Results of Long-acting Subcutaneous Lenacapavir in Treatment-Naive Patients
Slidesets REACH: Adherence to Dapivirine Vaginal Ring and Oral PrEP Among Adolescent Girls and Young Women in Africa
Slidesets GEMS: ART Resistance in Persons Diagnosed With HIV After PrEP Rollout in Sub-Saharan Africa
Slidesets CAPELLA: Week 26 Results of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced Patients

Key studies to be presented at the 11th IAS Conference on HIV Science, from International Co-Chair and IAS President, Dr. Adeeba Kamarulzaman

Adeeba Kamarulzaman, MBBS, FRACP, FASc Released: July 19, 2021
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Gilead Sciences, Inc.
Merck Sharp & Dohme Corp.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue